You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 15, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Hideki Ueno1, Nathalie Schmitt, Eynav Klechevsky
1Baylor Institute for Immunology Research and INSERM U899, Dallas, TX 75204, USA.
Dendritic cells (DCs) bridge innate and adaptive immunity, influencing immune responses like immunity and tolerance. Understanding DC plasticity and subsets is key to human disease research and vaccine development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: